Quantum Biopharma Ltd. Files May 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: May 21, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | May 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, regulatory-update
TL;DR
Quantum Biopharma (fka FSD Pharma) filed their monthly 6-K, confirming they use Form 20-F for annual reports.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on May 21, 2025. The company, incorporated in A6 with its principal executive office in Toronto, Canada, is in the Pharmaceutical Preparations industry. This filing is for the month of May 2025 and indicates the company files annual reports under Form 20-F.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Quantum Biopharma's ongoing reporting obligations as a foreign private issuer.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not appear to contain significant new financial or operational information.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer of the report
- FSD Pharma Inc. (company) — Former name of the filer
- May 21, 2025 (date) — Filing date
- Form 6-K (document) — Type of SEC filing
- Form 20-F (document) — Annual report form used by the company
- Toronto, Ontario (location) — Location of principal executive office
FAQ
What is the primary business of Quantum Biopharma Ltd.?
Quantum Biopharma Ltd. is in the Pharmaceutical Preparations industry, SIC code 2834.
When was the company formerly known as?
The company was formerly known as FSD Pharma Inc., with a name change date of March 27, 2019.
What is the filing date of this Form 6-K?
This Form 6-K was filed on May 21, 2025.
Does Quantum Biopharma file annual reports under Form 20-F or 40-F?
Quantum Biopharma indicates it files annual reports under cover of Form 20-F.
Where are Quantum Biopharma's principal executive offices located?
The principal executive offices are located at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 21, 2025 regarding Quantum Biopharma Ltd. (QNTM).